Publication An Insight into the Success, Challenges, and Future Perspectives of Eliminating Neglected Tropical Disease Hudu SA, Jimoh AO, Adeshina KA, et al. Elsevier BV. Scientific African. 2024; Download PDF
Publication Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope. Masiyiwa T, Bockarie M. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2024; Download PDF
Publication Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review. McPherson S, Solomon A, Seife F, et al. PLoS neglected tropical diseases. 2023; 17 (6) : 1-10. Download PDF
Publication Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial Laman M, Tavul L, Karl S, et al. Elsevier BV. The Lancet Infectious Diseases. 2022; Download PDF
Publication Yaws recurrence in children at continued risk of infection. Gonzalez-Beiras C, Marks M, Quintó L, et al. PLoS neglected tropical diseases. 2022; 16 (3) : e0010197. Download PDF
Publication An ODE model of yaws elimination in Lihir Island, Papua New Guinea Kimball P, Levenson J, Moore A, et al. PeerJ. PeerJ. 2022; Download PDF
Publication Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial Tavul L, Laman M, Howard C, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (2) : e0010096. Download PDF
Publication Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication John LN, Beiras CG, Houinei W, et al. Massachusetts Medical Society. New England Journal of Medicine. 2022; 386 (1) : 47-56. Download PDF